Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Long-serving Roche chief executive Severin Schwan is stepping down, to be replaced next March by Thomas Schinecker, currently head of diagnostics at the Swiss group. Schwan (pictured above ...

Stone Ridge 2059 Inflationprotected Longevity Inc is listed on the CBOE trading with ticker code LIAT.US. It has a market capitalisation of -, with approximately 16.00k shares in issue.

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

« Le centre de mon monde, c’était le port du Pouliguen » : l’enfance sur l’eau du skipper Loïck Peyron ...

Get full, unrestricted access to all of ch-aviation's news and data for 14 days.